Literature DB >> 11090068

Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells.

V Bronte1, E Apolloni, A Cabrelle, R Ronca, P Serafini, P Zamboni, N P Restifo, P Zanovello.   

Abstract

Apoptotic death of CD8(+) T cells can be induced by a population of inhibitory myeloid cells that are double positive for the CD11b and Gr-1 markers. These cells are responsible for the immunosuppression observed in pathologies as dissimilar as tumor growth and overwhelming infections, or after immunization with viruses. The appearance of a CD11b(+)/Gr-1(+) population of inhibitory macrophages (iMacs) could be attributed to high levels of granulocyte-macrophage colony-stimulating factor (GM-CSF) in vivo. Deletion of iMacs in vitro or in vivo reversed the depression of CD8(+) T-cell function. We isolated iMacs from the spleens of immunocompromised mice and found that these cells were positive for CD31, ER-MP20 (Ly-6C), and ER-MP58, markers characteristic of granulocyte/monocyte precursors. Importantly, although iMacs retained their inhibitory properties when cultured in vitro in standard medium, suppressive functions could be modulated by cytokine exposure. Whereas culture with the cytokine interleukin 4 (IL-4) increased iMac inhibitory activity, these cells could be differentiated into a nonadherent population of fully mature and highly activated dendritic cells when cultured in the presence of IL-4 and GM-CSF. A common CD31(+)/CD11b(+)/Gr-1(+) progenitor can thus give rise to cells capable of either activating or inhibiting the function of CD8(+) T lymphocytes, depending on the cytokine milieu that prevails during antigen-presenting cell maturation. (Blood. 2000;96:3838-3846)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11090068      PMCID: PMC2734459     

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  43 in total

1.  Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice.

Authors:  B Pulendran; J Lingappa; M K Kennedy; J Smith; M Teepe; A Rudensky; C R Maliszewski; E Maraskovsky
Journal:  J Immunol       Date:  1997-09-01       Impact factor: 5.422

2.  Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony-stimulating factor and contained CD34+ natural suppressor cells.

Authors:  M R Young; M A Wright; Y Lozano; M M Prechel; J Benefield; J P Leonetti; S L Collins; G J Petruzzelli
Journal:  Int J Cancer       Date:  1997-02-20       Impact factor: 7.396

Review 3.  Dendritic cells and the control of immunity.

Authors:  J Banchereau; R M Steinman
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

Review 4.  Membrane molecules as differentiation antigens of murine macrophages.

Authors:  A J McKnight; S Gordon
Journal:  Adv Immunol       Date:  1998       Impact factor: 3.543

Review 5.  Dramatic numerical increase of functionally mature dendritic cells in FLT3 ligand-treated mice.

Authors:  E Maraskovsky; B Pulendran; K Brasel; M Teepe; E R Roux; K Shortman; S D Lyman; H J McKenna
Journal:  Adv Exp Med Biol       Date:  1997       Impact factor: 2.622

6.  High-level expression of the ER-MP58 antigen on mouse bone marrow hematopoietic progenitor cells marks commitment to the myeloid lineage.

Authors:  M F de Bruijn; R E Ploemacher; A E Mayen; J S Voerman; W A Slieker; W van Ewijk; P J Leenen
Journal:  Eur J Immunol       Date:  1996-12       Impact factor: 5.532

7.  Mechanisms of tumor-induced immunosuppression: evidence for contact-dependent T cell suppression by monocytes.

Authors:  M L Jaffe; H Arai; G J Nabel
Journal:  Mol Med       Date:  1996-11       Impact factor: 6.354

8.  Human prostate carcinoma cell lines secrete GM-CSF and express GM-CSF-receptor on their cell surface.

Authors:  O W Rokhlin; T L Griebling; N V Karassina; M A Raines; M B Cohen
Journal:  Anticancer Res       Date:  1996 Mar-Apr       Impact factor: 2.480

9.  Bone marrow cellular composition in Listeria monocytogenes infected mice detected using ER-MP12 and ER-MP20 antibodies: a flow cytometric alternative to differential counting.

Authors:  M F de Bruijn; W van Vianen; R E Ploemacher; I A Bakker-Woudenberg; P A Campbell; W van Ewijk; P J Leenen
Journal:  J Immunol Methods       Date:  1998-08-01       Impact factor: 2.303

10.  A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis.

Authors:  G Süss; K Shortman
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

View more
  200 in total

Review 1.  Myeloid-derived suppressor cells in transplantation and cancer.

Authors:  Jordi C Ochando; Shu Hsia Chen
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

2.  Effects of allogeneic hematopoietic stem cell transplantation plus thymus transplantation on malignant tumors: comparison between fetal, newborn, and adult mice.

Authors:  Yuming Zhang; Naoki Hosaka; Yunze Cui; Ming Shi; Susumu Ikehara
Journal:  Stem Cells Dev       Date:  2010-09-13       Impact factor: 3.272

Review 3.  The multiple roles of monocyte subsets in steady state and inflammation.

Authors:  Clinton S Robbins; Filip K Swirski
Journal:  Cell Mol Life Sci       Date:  2010-05-01       Impact factor: 9.261

Review 4.  AACR centennial series: the biology of cancer metastasis: historical perspective.

Authors:  James E Talmadge; Isaiah J Fidler
Journal:  Cancer Res       Date:  2010-07-07       Impact factor: 12.701

5.  Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans.

Authors:  Güllü Topal Görgün; Gregory Whitehill; Jennifer L Anderson; Teru Hideshima; Craig Maguire; Jacob Laubach; Noopur Raje; Nikhil C Munshi; Paul G Richardson; Kenneth C Anderson
Journal:  Blood       Date:  2013-01-15       Impact factor: 22.113

6.  MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs.

Authors:  Giovanni Sitia; Masanori Isogawa; Matteo Iannacone; Iain L Campbell; Francis V Chisari; Luca G Guidotti
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

7.  The mouse mammary carcinoma 4T1: characterization of the cellular landscape of primary tumours and metastatic tumour foci.

Authors:  Sally A DuPré; Doug Redelman; Kenneth W Hunter
Journal:  Int J Exp Pathol       Date:  2007-10       Impact factor: 1.925

8.  Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo.

Authors:  Venkatesh L Hegde; Udai P Singh; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

9.  Bone marrow-derived angiogenic cells restore lung alveolar and vascular structure after neonatal hyperoxia in infant mice.

Authors:  Vivek Balasubramaniam; Sharon L Ryan; Gregory J Seedorf; Emily V Roth; Thatcher R Heumann; Mervin C Yoder; David A Ingram; Christopher J Hogan; Neil E Markham; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-12-11       Impact factor: 5.464

10.  Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination.

Authors:  Carmela De Santo; Paolo Serafini; Ilaria Marigo; Luigi Dolcetti; Manlio Bolla; Piero Del Soldato; Cecilia Melani; Cristiana Guiducci; Mario P Colombo; Manuela Iezzi; Piero Musiani; Paola Zanovello; Vincenzo Bronte
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.